Desiree C. Van Der Kleij

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Soft tissue infection after photoselective vaporization of the prostate: a life-threating complication.

Soft tissue infection after photoselective vaporization of the prostate: a life-threating complication.

Journal: The Netherlands journal of medicine

Published: July 03, 2019

Prevalence of Anti-infliximab Antibodies and Their Associated Co-factors in Children with Refractory Arthritis and/or Uveitis: A Retrospective Longitudinal Cohort Study.

Prevalence of Anti-infliximab Antibodies and Their Associated Co-factors in Children with Refractory Arthritis and/or Uveitis: A Retrospective Longitudinal Cohort Study.

Journal: The Journal of rheumatology

Published: November 24, 2016

Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis.

Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: August 11, 2015

Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.

Comparing a tapering strategy to the standard dosing regimen of TNF inhibitors in rheumatoid arthritis patients with low disease activity.

Journal: Clinical and experimental rheumatology

Published: June 03, 2015

Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity.

Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity.

Journal: The Journal of rheumatology

Published: May 14, 2015

Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis.

Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis.

Journal: Gastroenterology

Published: December 19, 2014

Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patients.

Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patients.

Journal: Journal of immunological methods

Published: November 21, 2014

Golimumab trough levels, antidrug antibodies and clinical response in patients with rheumatoid arthritis treated in daily clinical practice.

Golimumab trough levels, antidrug antibodies and clinical response in patients with rheumatoid arthritis treated in daily clinical practice.

Journal: Annals of the rheumatic diseases

Published: September 28, 2014

Extent and consequences of antibody formation against adalimumab in patients with psoriasis: one-year follow-up.

Extent and consequences of antibody formation against adalimumab in patients with psoriasis: one-year follow-up.

Journal: JAMA dermatology

Published: December 20, 2013

Key findings towards optimising adalimumab treatment: the concentration-effect curve.

Key findings towards optimising adalimumab treatment: the concentration-effect curve.

Journal: Annals of the rheumatic diseases

Published: December 12, 2013

Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up.

Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up.

Journal: Annals of the rheumatic diseases

Published: December 12, 2013

Reply to Ruiz-Argüello et al.: Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels.

Reply to Ruiz-Argüello et al.: Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels.

Journal: Clinical chemistry and laboratory medicine

Published: July 19, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026